Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

New discovery reveals an entire new world smaller than viruses and bacteria.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

Similar to the Democratic senators who have come out forcefully against Kennedy, Cassidy, in an interview with Fox News ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and he ...

Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

To his credit, Schaltz-Buchholzer criticizes RFK Jr for claiming that MMR causes autism and that the HPV vaccine causes ...

The only natural host of the hepatitis C virus (HCV) is humans. Model organisms for laboratory studies, especially mice, ...